loadpatents
name:-0.036426067352295
name:-0.014513969421387
name:-0.0021109580993652
Revert-Ros; Francisco Patent Filings

Revert-Ros; Francisco

Patent Applications and Registrations

Patent applications and USPTO patent grants for Revert-Ros; Francisco.The latest application filed is for "gpbp inhibition using q2 peptidomimetics".

Company Profile
1.9.15
  • Revert-Ros; Francisco - Valencia ES
  • REVERT-ROS; Francisco - Paterna Valencia
  • Revert-Ros; Francisco - Valcencia ES
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein
Grant 10,633,455 - Saus , et al.
2020-04-28
GPBP inhibition using Q.sub.2 peptidomimetics
Grant 10,544,083 - Saus , et al. Ja
2020-01-28
GPBP inhibition using Q2 peptidomimetics
App 20180179139 - Saus; Juan ;   et al.
2018-06-28
Methods for treating and diagnosing disease
App 20170218088 - Saus; Juan ;   et al.
2017-08-03
Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes
App 20170204197 - SAUS; Juan ;   et al.
2017-07-20
Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
App 20160184274 - Saus; Juan ;   et al.
2016-06-30
GPBP inhibition using Q2 peptidomimetics
App 20160083327 - Saus; Juan ;   et al.
2016-03-24
GPBP inhibition using Q2 peptidomimetics
Grant 9,199,936 - Saus , et al. December 1, 2
2015-12-01
GPBP-1 inhibition and its therapeutic use
Grant 9,066,938 - Saus , et al. June 30, 2
2015-06-30
Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes
App 20150093378 - SAUS; Juan ;   et al.
2015-04-02
GPBP inhibition using Q2 peptidomimetics
App 20140080852 - Saus; Juan ;   et al.
2014-03-20
GPBP-1 inhibition and its therapeutic use
App 20140005134 - Saus; Juan ;   et al.
2014-01-02
GPBP inhibition using Q.sub.2 peptidomimetics
Grant 8,586,776 - Saus , et al. November 19, 2
2013-11-19
Methods for treating and diagnosing disease
App 20120213800 - Saus; Juan ;   et al.
2012-08-23
GPBP inhibition using Q2 peptidomimetics
App 20110105545 - SAUS; JUAN ;   et al.
2011-05-05
GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
App 20100136014 - Saus; Juan ;   et al.
2010-06-03
GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
Grant 7,601,349 - Saus , et al. October 13, 2
2009-10-13
Novel Goodpasture Antigen-Binding Protein Isoforms and Protein Misfolded-Mediated Disorders
App 20080132452 - Saus; Juan ;   et al.
2008-06-05
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
Grant 7,326,768 - Saus , et al. February 5, 2
2008-02-05
GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
App 20070053915 - Saus; Juan ;   et al.
2007-03-08
GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
Grant 7,147,855 - Saus , et al. December 12, 2
2006-12-12
Novel Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
App 20040175758 - Saus, Juan ;   et al.
2004-09-09
GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
App 20030108554 - Saus, Juan ;   et al.
2003-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed